Informing health system planning for biomarker-based treatment: projections of cancer prevalence to 2042 for key pan-tumour biomarkers (dMMR, MSI, high TMB) — ASN Events
  1. Schedule
  2. Lunch & Poster Viewing (Even Numbers)
  3. Informing health system planning for biomarker-based treatment: projections of cancer prevalence to 2042 for key pan-tumour biomarkers (dMMR, MSI, high TMB)

Informing health system planning for biomarker-based treatment: projections of cancer prevalence to 2042 for key pan-tumour biomarkers (dMMR, MSI, high TMB) (#240)

Yoon-Jung Kang 1 , Qingwei Luo 1 , Jeff Cuff 1 , John Zalcberg 2 , Karen Canfell 1 , Julia Steinberg 1
  1. Daffodil Centre, Woolloomooloo, NSW, Australia
  2. Department of Medical Oncology, Alfred Health , Melbourne, VIC , Australia
Publish consent withheld
#NSWCancerConf2023